Clinical Trial Update: Neoadjuvant Immunotherapy for T4 dMMR Colon Cancer [NA]

View source ↗

Summary

A neoadjuvant immunotherapy trial for T4 colon cancer with mismatch repair deficiency is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Mismatch Repair Deficiency

Drugs mentioned

• Immunotherapy (unspecified)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Colon Cancer, Mismatch Repair Deficiency | NA | Status: RECRUITING